Infliximab first-line treatment for Crohn’s disease in children Jan. 24, 2023 Article: Gut. 2022 Jan;71(1):34-42. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial Reviewer: Dr. Erik Clutter